<DOC>
	<DOCNO>NCT02322307</DOCNO>
	<brief_summary>HealthPROMISE mobile application ( app ) patient allow regular track symptoms patient communicates physician . The purpose randomize control trial determine impact HealthPROMISE application improve patient outcome . The trial look much patient use application , whether physician change treatment response new information patient , patient quality life change span study . The investigator hypothesize HealthPROMISE enhance physician-patient communication improve clinical outcome .</brief_summary>
	<brief_title>Trial Impact HealthPROMISE Mobile App Inflammatory Bowel Disease Care Quality Life</brief_title>
	<detailed_description>This study prospectively enroll 300 patient Crohn 's Disease Ulcerative Colitis present Mount Sinai Health System . Eligible participant complete informed consent fill Tablet Web-based questionnaire end give pin offer download HealthPROMISE app education app . Patients download HealthPROMISE app request provide update quality metric , quality life questionnaire , emergency visit hospitalization . Data collect continuously throughout study use mobile health app . Study endpoint primarily assess use `` intention treat '' analysis . Additionally , per protocol analysis data perform patient logged application least 4 time 12 month . The total study duration 2 year ( 104 week ) . At 1 year ( 52 week ) , interim analysis do determine study need continue full 104 week . Furthermore , patient either arm login use PIN complete week 52 ( week 104 ) exit survey consider `` lose follow '' .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>Age &gt; 18 year , Internet Smartphone access Ability complete Tablet webbased questionnaire English language . Presence short bowel syndrome , stoma pouch . Presence condition disease , opinion investigator , may make exceedingly difficult patient use HealthPROMISE App , include , limited , advanced dementia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Inflammatory Bowel Disease</keyword>
	<keyword>Crohn 's Disease</keyword>
	<keyword>Ulcerative Colitis</keyword>
	<keyword>Colitis</keyword>
	<keyword>PRO</keyword>
	<keyword>Patient-centric</keyword>
	<keyword>HealthPROMISE</keyword>
</DOC>